New weight loss drugs aim to promote muscle growth
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.
Ozempic, Wegovy coverage demand adds to employer health-insurance costs
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
Novo Nordisk: Dips Like These Come Once Every Few Years
Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...
BioSpace8d
Lilly Signs Back-to-Back Deals in MASH, Cancer
Eli Lilly inked two collaborations on Monday, one focused on cardiometabolic diseases with South Korea’s OliX Pharmaceuticals ...
Medscape13d
Some Patients — And Doctors — Turn to Microdosing GLP-1s
Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...
Seeking Alpha14d
Novo Nordisk Q4 Earnings: Outperformance Suggests Stock Price Comeback Starts Today
Results from a longer-term study shared last year showed an average >10% loss after four years of use, against 1.5% for placebo ... 11.8% with cagrilintide 2.4 mg, 16.1% with semaglutide 2.4 ...
RTE Online14d
Novo Nordisk sees slower sales growth in 2025
US rival Eli Lilly last month forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ... 37% to 36.7 billion Danish crowns ($5.12 billion), better than the 33.6 billion ...
AOL14d
Prescriptions for weight loss drugs are skyrocketing, especially among young women. Experts think they know why.
In fact, Sipes’s weight was creeping back up. After diagnosing her with polycystic ovarian syndrome (PCOS), her doctor prescribed Zepbound to help with symptoms of the condition as well as ...
The Globe and Mail14d
Wegovy sales double to boost Novo Nordisk’s fourth quarter as growth set to slow
Its shares rose 5.3 per cent at 1027 GMT on Copenhagen ... last month forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street estimates, leading the stock to fall 8 per ...